Evidence map›Paper›PMID 41058879›Full record

ArticleHuman mutation2025

Vimentin Regulates Alternative Polyadenylation and mTOR Signaling via ARVCF to Promote B Cell Lymphoma Progression.

Lujing Shao, Qianke Xing, Yao Xiong, Kaidi Jin, Qi Li, Chunyan Dong, Qianling Ye

Erratum issuedAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Human mutation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Lujing ShaoDepartment of Oncology, East Hospital Affiliated to Tongji University, Tongji University School of Medicine, Tongji University, Shanghai, China.
Qianke XingDepartment of Oncology, East Hospital Affiliated to Tongji University, Tongji University School of Medicine, Tongji University, Shanghai, China.
Yao XiongTongji Hospital Affiliated to Tongji University, Tongji University School of Medicine, Tongji University, Shanghai, China.
Kaidi JinDepartment of Forensic Medicine, School of Basic Medical Sciences, Fudan University, Shanghai, China.
Qi LiDepartment of Oncology, East Hospital Affiliated to Tongji University, Tongji University School of Medicine, Tongji University, Shanghai, China.
Chunyan DongDepartment of Oncology, East Hospital Affiliated to Tongji University, Tongji University School of Medicine, Tongji University, Shanghai, China.ORCID 0000-0003-2392-3185
Qianling YeDepartment of Oncology, East Hospital Affiliated to Tongji University, Tongji University School of Medicine, Tongji University, Shanghai, China.ORCID 0009-0007-0391-7198

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Lymphoma, B-CellPolyadenylationTOR Serine-Threonine KinasesVimentin3' Untranslated RegionsCell Line, TumorDisease ProgressionGene Expression Regulation, NeoplasticHumansProteomicsSignal Transduction3' Untranslated RegionsMTOR protein, humanTOR Serine-Threonine KinasesVimentinVIM protein, humanalternative polyadenylationARVCFB cell lymphomamTOR signalingvimentin

Identifiers

PMID41058879
PMCPMC12497530

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.